Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03098550
What this trial is testing

Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 105
Testing effectiveness (Phase 2)Ended earlyNCT00539617
What this trial is testing

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 7
Testing effectiveness (Phase 2)Ended earlyNCT00036517
What this trial is testing

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDiarrhea
PhytoCeutica 30
Testing effectiveness (Phase 2)Looking for participantsNCT07789210
What this trial is testing

A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases

Who this might be right for
Colorectal CancerBRAF V600E Mutation PositiveEncorafenib+1 more
Zhejiang University 25
Testing effectiveness (Phase 2)Looking for participantsNCT07733180
What this trial is testing

A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma
BeOne Medicines 30
Testing effectiveness (Phase 2)UnknownNCT00425425
What this trial is testing

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Who this might be right for
Esophageal Cancer
Technical University of Munich 43
Not applicableUnknownNCT05280210
What this trial is testing

PTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal Tumor

Who this might be right for
Gastrointestinal Neoplasms
Peking University 420
Not applicableStudy completedNCT05137782
What this trial is testing

The Science of the Art of Palliative Care

Who this might be right for
Gastrointestinal CancerLung CancerAdvanced Cancer
Dartmouth-Hitchcock Medical Center 7
Early research (Phase 1)Study completedNCT01308723
What this trial is testing

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 6
Testing effectiveness (Phase 2)WithdrawnNCT01070290
What this trial is testing

ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen

Who this might be right for
Gastric Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Testing effectiveness (Phase 2)WithdrawnNCT04571710
What this trial is testing

A Trial of SHR1258 in Patients With Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Jiangsu HengRui Medicine Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT01932125
What this trial is testing

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms
Hoffmann-La Roche 100
Not applicableStudy completedNCT03323489
What this trial is testing

Celiac Plexus Radio-Surgery for Pain Management

Who this might be right for
Advanced CancerPancreas CancerPain
Dr. Yaacov Lawrence 125
Not applicableUnknownNCT02618850
What this trial is testing

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

Who this might be right for
Colorectal Cancer Stage IV
National Cancer Institute, Naples 260
Large-scale testing (Phase 3)Looking for participantsNCT06793917
What this trial is testing

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 269
Early research (Phase 1)Study completedNCT02988440
What this trial is testing

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 20
Early research (Phase 1)Ended earlyNCT02952989
What this trial is testing

A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellBreast Neoplasms+5 more
Seagen Inc. 47
Testing effectiveness (Phase 2)Study completedNCT03606590
What this trial is testing

Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA)

Who this might be right for
Hepatocellular Carcinoma
NovoCure Ltd. 25
Testing effectiveness (Phase 2)Ended earlyNCT00320320
What this trial is testing

Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsMetastases
Gachon University Gil Medical Center 72
Not applicableStudy completedNCT00040820
What this trial is testing

Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute
Next Page